Preparing for the Bursting of the Psychedelic Hype Bubble.
David B. Yaden, James B. Potash, Roland R. Griffiths
JAMA Psychiatry October 1, 2022 DOI: 10.1001/jamapsychiatry.2022.2546 via PubMed
Summary
AI-generated from the abstractPublic perception of psychedelics has swung from extreme stigma to uncritical enthusiasm, creating obstacles for clinical application. This viewpoint argues that both poles are problematic and advocates for continued scientific study while encouraging critical examination of claims not supported by evidence. The authors call for a balanced approach that neither dismisses therapeutic potential nor overpromises benefits, emphasizing the need for rigorous research to guide responsible clinical integration.
Study at a glance
| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Psychedelic medicine Entheogenic treatment Hallucinogen-assisted therapy Mental health psychedelics |
| Citations | 153 |
| Key finding | Extreme shifts in public perception of psychedelics create impediments to clinical application, and claims not supported by evidence should be disputed. |
Abstract
This Viewpoint presents impediments to the clinical application of psychedelics created by extreme shifts in public perception while advocating further study and encouraging the dispute of claims not supported by available evidence.